Dr. Manmeet Ahluwalia, MD
Claim this profileMiami Cancer Institute at Baptist Health, Inc.
Area of expertise
Brain Tumor
Manmeet Ahluwalia, MD has run 7 trials for Brain Tumor. Some of their research focus areas include:
Lung Cancer
Manmeet Ahluwalia, MD has run 4 trials for Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Miami Cancer Institute At Baptist Health, Inc.
Miami Cancer Institute At Baptist Health
Clinical Trials Manmeet Ahluwalia, MD is currently running
Focused Ultrasound + Immunotherapy
for Brain Cancer
The purpose of this study is to evaluate the safety and efficacy of targeted blood brain barrier opening with Exablate Model 4000 Type 2.0/2.1 for the treatment of NSCLC brain metastases in patients who are undergoing planned FDA approved, on-label systemic therapy utilizing immune checkpoint inhibitors.
Recruiting
3 awards
Phase 3
cfDNA Assay
for Cancer Detection
This is an observational case-control study to train and validate a genome-wide methylome enrichment platform to detect multiple cancer types and to differentiate amongst cancer types. The cancers included in this study are brain, breast, bladder, cervical, colorectal, endometrial, esophageal, gastric, head and neck, hepatobiliary, leukemia, lung, lymphoma, multiple myeloma, ovarian, pancreatic, prostate, renal, sarcoma, and thyroid. These cancers were selected based on their prevalence and mortality to maximize impact on clinical care. Additionally, the ability of the whole-genome methylome enrichment platform to detect minimal residual disease after completion of cancer treatment and to detect relapse prior to clinical presentation will be evaluated in lung cancer. This cancer was selected based on the existing clinical landscape and treatment availability.
Recruiting
1 award
N/A
3 criteria
More about Manmeet Ahluwalia, MD
Clinical Trial Related
1 year of experience running clinical trials · Led 8 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Manmeet Ahluwalia, MD has experience with
- Capecitabine
- Stereotactic Radiosurgery
- Trastuzumab
- Tucatinib
- Exablate Model 4000 Type 2.0/2.1
- Pembrolizumab
Breakdown of trials Manmeet Ahluwalia, MD has run
Brain Tumor
Lung Cancer
Breast Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Manmeet Ahluwalia, MD specialize in?
Manmeet Ahluwalia, MD focuses on Brain Tumor and Lung Cancer. In particular, much of their work with Brain Tumor has involved Stage IV patients, or patients who are HER2 positive.
Is Manmeet Ahluwalia, MD currently recruiting for clinical trials?
Yes, Manmeet Ahluwalia, MD is currently recruiting for 2 clinical trials in Miami Florida. If you're interested in participating, you should apply.
Are there any treatments that Manmeet Ahluwalia, MD has studied deeply?
Yes, Manmeet Ahluwalia, MD has studied treatments such as Capecitabine, Stereotactic Radiosurgery, Trastuzumab.
What is the best way to schedule an appointment with Manmeet Ahluwalia, MD?
Apply for one of the trials that Manmeet Ahluwalia, MD is conducting.
What is the office address of Manmeet Ahluwalia, MD?
The office of Manmeet Ahluwalia, MD is located at: Miami Cancer Institute at Baptist Health, Inc., Miami, Florida 33176 United States. This is the address for their practice at the Miami Cancer Institute at Baptist Health, Inc..
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.